Specializing in biopharmaceutical research and development, the focus is on prescription products for ophthalmic and pulmonary diseases, with key compounds in advanced clinical stages for conditions like cystic fibrosis and dry eye. The portfolio includes innovative treatments and collaborations for various ophthalmic conditions.